Study to Evaluate Safety and Biological Activity of TroVax® Vaccine Given in Conjunction With IL-2 to Treat Locally Advanced or Metastatic Renal Cell Carcinoma

This study has been completed.
Sponsor:
Collaborators:
The Methodist Hospital System
ORION Clinical Services
Information provided by:
Oxford BioMedica
ClinicalTrials.gov Identifier:
NCT00325507
First received: May 10, 2006
Last updated: July 31, 2008
Last verified: July 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)